Home › Sun Pharma Declines as Regulatory Issue Puts Pressure on Profit
 

Keywords :   


Sun Pharma Declines as Regulatory Issue Puts Pressure on Profit

2015-02-16 08:49:03| Chemicals - Topix.net

Sun Pharmaceutical Industries Ltd., India's largest drugmaker, fell in Mumbai trading as quarterly profit came under pressure from efforts to address regulatory issues at one of its factories. Sun Pharma fell as much as 3.5 percent to 907.30 rupees in Mumbai today before trading at 915.25 rupees at 9:34 a.m. local time, the biggest decliner on the benchmark S&P BSE Sensex Index.

Tags: issue sun pressure profit

Category:Chemicals

Latest from this category

All news
01.07Beckers Group Announces Leadership Changes
01.07BASFs TECH Academy Introduces Louisiana High School Students to Technical Careers
29.06Weekly Recap: PPG, Hempel, Beckers Group Top This Weeks Stories
28.06Jotun Launches CX-Rated Anticorrosive Powder Coating
28.06RPM to Announce Fiscal 2024 4Q, Year-End Results
28.06Evonik Commissions New Plant for AEROSIL Silicas
28.06BCFs Coatings Ambassador Program Trains Its 50th Ambassador
28.06Global Green Building Alliance Launches Guide to Net Zero
Chemicals »
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Public Advisory Number 14A
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Atlantic Tropical Weather Outlook
02.07Eastern North Pacific Tropical Weather Outlook
02.07Murdoch Netflix rival to launch in UK
02.07Hurricane Beryl Forecast Discussion Number 14
02.07Hurricane Beryl Graphics
More »